A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation

Bone marrow examination shows hematological recurrence;

Have malignant tumors within 5 years before screening;

Subjects with acute promyelocytic leukemia(APL);

Subjects with severe respiratory diseases;